| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 800.000 | 5 | Oct-29 | Sr. Secured | - | BB | BB | Fixed | YLD | 7.25% a | 6.9% | - | 6.67% | - | 99.04100 |
Tranche Comments
5 yr: Book size: 1800; Registration: 144A/Reg S; Comments: USD800m 5NC2 snr sec RegS/144A. BB/BB. BofA/Citi/HSBC(B&D)/StCh/BNPP/Miz. IPG Yld 7.25% area, FPG 6.9%. TBP today. Number of Accounts: 138. Distribution: By Region: US 47% EMEA 27% Asia 26% By Type: AM/FM 90% Ins/Banks 8% PB/Corps/Other 2%;
Guarantor(s)
Biocon Biologics, Biosimilars New Co Ltd (UK), Biocon Biologics UK, Biocon SDN BHD, Malaysia, Biosimilar Collaborations Ireland
Use of Proceeds
Repay debt